© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
May 08, 2021
Research at ARVO 2021 highlighted a gamut of interplaying diabetes and vision loss risk factors, and even treatments for both. But experts depict a referral and care process that lacks whole diabetes care.
May 07, 2021
A podcast interview with study author Paul Yang, MD, PhD, on the current research and future implementation of the agent.
May 06, 2021
The diabetes and ophthalmology overlap is significant and growing in the US. A Cleveland Clinic expert discusses crossover research and care.
May 05, 2021
A discussion with an investigator on how the SGLT-2 inhibitor may help affected patients.